Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
This study is ongoing, but not recruiting participants.
Study NCT00314262   Information provided by Emory University

First Received on April 11, 2006.   Last Updated on February 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Precancerous Conditions
More general conditions related to this trial
Neoplasms
Interventions listed in this trial
Erlotinib & Celecoxib
Additional drug interventions recognized in this trial
Celecoxib
Cyclooxygenase 2 Inhibitors
Erlotinib
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protein Kinase Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Emory University
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services